BioPharma Resources

Drug Trial Radar · NCT07481981

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 344 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

344

Planned (sponsor's estimate)

Start

Jul 21, 2026

Primary completion

Dec 28, 2028

Study completion Jan 28, 2029

Sponsor

Lead sponsor
Insmed IncorporatedIndustry
Sponsor type
Industry
First posted
Mar 19, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP compared with placebo on exercise capacity in adults with PAH.

Conditions

  • Pulmonary Arterial Hypertension

Interventions

  • Treprostinil Palmitil Inhalation PowderDrug

    Oral inhalation using a capsule-based dry powder inhaler device.

  • PlaceboDrug

    Oral inhalation using a capsule-based dry powder inhaler device.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in 6-Minute Walk Distance (6MWD) Measured at 1 to 3 Hours Post-Dose From Baseline at Week 24Time frame: Baseline, Week 24

Locations

39 sites in 8 countries. Site status is shown where the registry gives one.

  • USA012

    Los Angeles, California · Recruiting

  • USA008

    Santa Barbara, California · Recruiting

  • USA005

    Torrance, California · Recruiting

  • USA010

    Kansas City, Kansas · Recruiting

  • USA028

    Omaha, Nebraska · Recruiting

  • USA022

    New Hyde Park, New York · Recruiting

  • USA011

    New York, New York · Recruiting

  • USA015

    New York, New York · Recruiting

  • USA013

    Rochester, New York · Recruiting

  • USA006

    Philadelphia, Pennsylvania · Recruiting

  • USA007

    Anderson, South Carolina · Recruiting

  • ARG001

    Buenos Aires, Buenos Aires F.D., Argentina · Recruiting

  • ARG004

    Río Cuarto, Córdoba Province, Argentina · Recruiting

  • ARG005

    San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting

  • AUS002

    Camperdown, New South Wales, Australia · Recruiting

  • AUS003

    Westmead, New South Wales, Australia · Recruiting

  • ISR002

    Haifa, Israel · Recruiting

  • ISR001

    Jerusalem, Israel · Recruiting

  • ISR004

    Petah Tikva, Israel · Recruiting

  • ISR005

    Ramat Gan, Israel · Recruiting

  • ISR003

    Tel Aviv, Israel · Recruiting

  • JPN016

    Chiba, Chiba, Japan · Recruiting

  • JPN011

    Narashino, Chiba, Japan · Recruiting

  • JPN015

    Yahatanishi-ku, Kita Kyushu-shi, Fukuoka, Japan · Recruiting

  • JPN007

    Sapporo, Hokkaido, Japan · Recruiting

  • JPN002

    Sapporo, Hokkaido, Japan · Recruiting

  • JPN014

    Kobe, Hyōgo, Japan · Recruiting

  • JPN003

    Okayama, Okayama-ken, Japan · Recruiting

  • JPN017

    Minato-ku, Tokyo, Japan · Recruiting

  • JPN004

    Mitaka-shi, Tokyo, Japan · Recruiting

  • NZL001

    Auckland, New Zealand · Recruiting

  • NZL003

    Dunedin, New Zealand · Recruiting

  • NZL002

    Hamilton, New Zealand · Recruiting

  • KOR006

    Busan, South Korea · Recruiting

  • KOR003

    Incheon, South Korea · Recruiting

  • KOR002

    Seoul, South Korea · Recruiting

  • KOR005

    Seoul, South Korea · Recruiting

  • KOR001

    Seoul, South Korea · Recruiting

  • TWN002

    Taipei, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.